ask="4.83"
ask_size="800"
average_daily_volume="251034"
bid="3.19"
bid_size="100"
book_value="0.74"
change="+0.26"
change_from_200_day_moving_average="1.86"
change_from_50_day_moving_average="1.32"
change_from_52_week_high="-0.45"
change_From_52_week_low="3.33"
change_in_percent="+5.73%"
close="4.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="19694000"
high="5.25"
high_52_weeks="5.25"
last_trade_date="3/10/2017"
last_trade_price="4.80"
last_trade_size="1990"
last_trade_time="4:00pm"
low="4.50"
low_52_weeks="1.47"
market_capitalization="163.91M"
moving_average_200_day="2.94"
moving_average_50_day="3.48"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="6.75"
open="4.65"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+63.47%"
percent_change_from_50_day_moving_average="+37.97%"
percent_change_from_52_week_high="-8.57%"
percent_change_from_52_week_low="+226.53%"
previous_close="4.54"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.11"
price_per_sales="34.83"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="2.29"
stock_exchange="NGM"
symbol="FATE"
volume="1587145"
weeks_range_52="1.47 - 5.25"
